Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York. more
Time Frame | PRPH | Sector | S&P500 |
---|---|---|---|
1-Week Return | -15.34% | 0.31% | -1.26% |
1-Month Return | -11.73% | 0.6% | -4.16% |
3-Month Return | -74.77% | -9.44% | -0.46% |
6-Month Return | -81.2% | -5.15% | 3.58% |
1-Year Return | -87.89% | 0.33% | 22.47% |
3-Year Return | -91.71% | 4.53% | 25.13% |
5-Year Return | -66.91% | 35.98% | 77.7% |
10-Year Return | -62.85% | 100.72% | 190.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 9.88M | 14.51M | 79.04M | 122.65M | 44.38M | [{"date":"2019-12-31","value":8.05,"profit":true},{"date":"2020-12-31","value":11.83,"profit":true},{"date":"2021-12-31","value":64.45,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":36.19,"profit":true}] |
Cost of Revenue | 7.26M | 9.91M | 46.23M | 51.99M | 28.14M | [{"date":"2019-12-31","value":13.97,"profit":true},{"date":"2020-12-31","value":19.06,"profit":true},{"date":"2021-12-31","value":88.91,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":54.13,"profit":true}] |
Gross Profit | 2.62M | 4.61M | 32.81M | 70.65M | 16.24M | [{"date":"2019-12-31","value":3.7,"profit":true},{"date":"2020-12-31","value":6.52,"profit":true},{"date":"2021-12-31","value":46.44,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.98,"profit":true}] |
Gross Margin | 26.48% | 31.73% | 41.51% | 57.61% | 36.59% | [{"date":"2019-12-31","value":45.96,"profit":true},{"date":"2020-12-31","value":55.09,"profit":true},{"date":"2021-12-31","value":72.06,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.51,"profit":true}] |
Operating Expenses | 5.85M | 8.59M | 23.01M | 47.06M | 37.85M | [{"date":"2019-12-31","value":12.44,"profit":true},{"date":"2020-12-31","value":18.26,"profit":true},{"date":"2021-12-31","value":48.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.44,"profit":true}] |
Operating Income | (3.24M) | (3.98M) | 9.80M | 23.59M | (21.61M) | [{"date":"2019-12-31","value":-13.73,"profit":false},{"date":"2020-12-31","value":-16.89,"profit":false},{"date":"2021-12-31","value":41.54,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-91.6,"profit":false}] |
Total Non-Operating Income/Expense | 266.00K | (454.00K) | (5.00M) | (1.30M) | (2.03M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-170.68,"profit":false},{"date":"2021-12-31","value":-1880.45,"profit":false},{"date":"2022-12-31","value":-487.97,"profit":false},{"date":"2023-12-31","value":-762.41,"profit":false}] |
Pre-Tax Income | (3.11M) | (2.33M) | 5.30M | 22.91M | (22.80M) | [{"date":"2019-12-31","value":-13.56,"profit":false},{"date":"2020-12-31","value":-10.15,"profit":false},{"date":"2021-12-31","value":23.16,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-99.53,"profit":false}] |
Income Taxes | (93.00K) | 94.00K | (968.00K) | 4.45M | (6.02M) | [{"date":"2019-12-31","value":-2.09,"profit":false},{"date":"2020-12-31","value":2.11,"profit":true},{"date":"2021-12-31","value":-21.78,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-135.39,"profit":false}] |
Income After Taxes | (3.01M) | (2.42M) | 6.27M | 18.46M | (16.78M) | [{"date":"2019-12-31","value":-16.32,"profit":false},{"date":"2020-12-31","value":-13.11,"profit":false},{"date":"2021-12-31","value":33.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-90.9,"profit":false}] |
Income From Continuous Operations | (3.11M) | (2.33M) | 6.27M | 18.46M | (10.47M) | [{"date":"2019-12-31","value":-16.82,"profit":false},{"date":"2020-12-31","value":-12.6,"profit":false},{"date":"2021-12-31","value":33.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-56.74,"profit":false}] |
Income From Discontinued Operations | (40.00K) | 201.00K | - | - | - | [{"date":"2019-12-31","value":-19.9,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (3.01M) | (2.42M) | 6.27M | 18.46M | (16.78M) | [{"date":"2019-12-31","value":-16.32,"profit":false},{"date":"2020-12-31","value":-13.11,"profit":false},{"date":"2021-12-31","value":33.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-90.9,"profit":false}] |
EPS (Diluted) | (0.28) | (0.33) | 0.81 | 1.02 | (0.98) | [{"date":"2019-12-31","value":-27.45,"profit":false},{"date":"2020-12-31","value":-32.35,"profit":false},{"date":"2021-12-31","value":79.41,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-96.08,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
PRPH | |
---|---|
Cash Ratio | 0.02 |
Current Ratio | 1.47 |
Quick Ratio | 1.33 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
PRPH | |
---|---|
ROA (LTM) | -22.98% |
ROE (LTM) | -50.92% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
PRPH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.58 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.42 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
PRPH | |
---|---|
Trailing PE | NM |
Forward PE | 10.09 |
P/S (TTM) | 0.86 |
P/B | 0.41 |
Price/FCF | NM |
EV/R | 3.50 |
EV/Ebitda | 2.45 |
PEG | NM |
ProPhase Labs Inc (PRPH) share price today is $0.6055
Yes, Indians can buy shares of ProPhase Labs Inc (PRPH) on Vested. To buy ProPhase Labs Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PRPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of ProPhase Labs Inc (PRPH) via the Vested app. You can start investing in ProPhase Labs Inc (PRPH) with a minimum investment of $1.
You can invest in shares of ProPhase Labs Inc (PRPH) via Vested in three simple steps:
The 52-week high price of ProPhase Labs Inc (PRPH) is $7.48. The 52-week low price of ProPhase Labs Inc (PRPH) is $0.56.
The price-to-earnings (P/E) ratio of ProPhase Labs Inc (PRPH) is
The price-to-book (P/B) ratio of ProPhase Labs Inc (PRPH) is 0.41
The dividend yield of ProPhase Labs Inc (PRPH) is 0.00%
The market capitalization of ProPhase Labs Inc (PRPH) is $14.46M
The stock symbol (or ticker) of ProPhase Labs Inc is PRPH